We are pioneers in the diagnosis of Alzheimer's disease
Our goal is to ensure timely access to our early diagnostic test for diverse populations around the world, in order to mitigate the negative impacts of this disease and improve the quality of life of patients and their caregivers
COMPAny
We have developed a simple, economical, non-invasive, and highly analytically performing biomarker as a tool to aid in the diagnosis of Alzheimer’s disease and Mild Cognitive Impairment associated with Alzheimer’s. This tool has great potential to be used in population screening.
